Autopsy report · NCT03252171

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

“Project terminated due to revision of local regulations”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Fuda Cancer Hospital, Guangzhou

Sponsor type

University, hospital or other

Conditions

GD2 Positive Glioma; CAR-T Cell Immunotherapy

Interventions

CAR-T cell immunotherapy

Participants

0

Sites

1

Countries

China

Trials that died the same way

• FUNctional eFficacy of Hybrid coronAry REvascularization
  “The local research project is cancelled because of the organizational issues” (64% match in meaning)
• Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
  “Project was stopped due to futility” (62% match in meaning)
• KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study
  “Due to a strategic adjustment, the company has decided to terminate the project.” (60% match in meaning)
• GALLANT 22 Tesaglitazar vs. Placebo
  “The development program has been terminated” (59% match in meaning)
• Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
  “Study was terminated due to a business decision to cancel the entire project.” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.